Device Trial Radar · NCT06997549
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Last checked: Nov 19, 2026Latest source record: Apr 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
12,000
Planned (sponsor's estimate)
Start
May 15, 2025
Primary completion
Dec 2035
Study completion Dec 2035
Sponsor
- Lead sponsor
- NeuroneticsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 30, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 5 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness
Conditions
- Depression
- OCD
- Anxiety Depression
Interventions
Patients treated with NeuroStar TMSDevice
non-invasive brain stimulation device
Patients treated with EsketamineDrug
nasal spray for treating depression
Primary outcomes
What the sponsor says the trial is designed to measure.
- change in clinical outcome scores from baseline to post treatmentTime frame: 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Neuronetics
Malvern, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.